What is the appropriate management for hemorrhagic gastritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hemorrhagic Gastritis

Hemorrhagic gastritis should be managed with aggressive resuscitation, early endoscopy within 24 hours, high-dose proton pump inhibitor therapy, and endoscopic hemostasis for high-risk stigmata, while surgery is reserved only as a last resort after all medical and endoscopic options have been exhausted. 1

Initial Resuscitation and Stabilization

  • Prioritize aggressive volume resuscitation and hemodynamic stabilization before attempting to identify the bleeding source 1
  • Use restrictive red blood cell transfusion thresholds: hemoglobin trigger of 70 g/L (target 70-90 g/L) in stable patients without cardiovascular disease 1
  • For patients with cardiovascular disease, use a higher transfusion threshold of 80 g/L (target 100 g/L) 1
  • If the patient remains hemodynamically unstable with shock index >1 after initial resuscitation, proceed urgently to CT angiography to localize bleeding before planning intervention 1

Endoscopic Evaluation and Timing

  • Perform upper endoscopy (esophagogastroduodenoscopy) within 24 hours of presentation as the primary diagnostic and therapeutic modality 1
  • Upper endoscopy successfully identifies the bleeding source in 95% of cases and allows for immediate therapeutic intervention 1
  • Emergency endoscopy is indicated for patients with persistent hemorrhage causing hemodynamic instability or requiring repeated transfusions 1

Pharmacologic Therapy

Proton Pump Inhibitors

  • Initiate high-dose proton pump inhibitor therapy immediately, even before endoscopy 1
  • The optimal regimen is omeprazole 80 mg IV bolus followed by continuous infusion of 8 mg/hour (or 40 mg IV every 8 hours) for high-risk patients 1
  • For lower-risk patients, oral omeprazole 40 mg every 12 hours for 5 days is an acceptable alternative 1
  • PPI therapy may downstage endoscopic lesions and decrease the need for endoscopic intervention, but should not delay endoscopy 1

Special Consideration for Cirrhotic Patients

  • If the patient has cirrhosis, immediately start antibiotic prophylaxis with ceftriaxone 1 g IV once daily for up to 7 days, regardless of whether varices are the source 2
  • This reduces infection rates, mortality, and rebleeding in cirrhotic patients with any upper GI bleeding 2

Endoscopic Hemostatic Therapy

Risk Stratification at Endoscopy

  • Low-risk stigmata (clean-based ulcer or flat pigmented spot) do not require endoscopic hemostatic therapy 1
  • High-risk stigmata (active bleeding or visible vessel) mandate immediate endoscopic hemostatic intervention 1
  • For adherent clots, attempt targeted irrigation to dislodge; if a high-risk lesion is revealed underneath, treat it endoscopically 1

Hemostatic Techniques

  • Use combination therapy rather than epinephrine injection alone, as epinephrine monotherapy provides suboptimal efficacy 1
  • Thermocoagulation (bipolar, heater probe, or argon plasma coagulation) or sclerosant injection combined with epinephrine are first-line endoscopic therapies 1, 3
  • Through-the-scope clips are an alternative option for focal bleeding points 1
  • For diffuse hemorrhagic gastritis where focal therapy is difficult, argon plasma coagulation has shown effectiveness in achieving hemostasis 3

Management of Refractory or Recurrent Bleeding

  • If bleeding recurs after initial endoscopic therapy, perform repeat endoscopy to confirm rebleeding and attempt endoscopic therapy one additional time 1
  • Patients who fail two attempts at endoscopic hemostasis should be considered for interventional radiology (angiography with embolization) or surgery 1
  • In centers with 24/7 interventional radiology, catheter angiography with embolization should be available within 60 minutes for hemodynamically unstable patients 1

Surgical Intervention

Indications and Timing

  • Surgery is an option of last resort, reserved only for patients with uncontrolled hemorrhage despite aggressive medical and endoscopic therapy 4, 5
  • No patient should proceed to emergency laparotomy unless every effort has been made to localize bleeding by radiological and/or endoscopic modalities 1
  • Avoid surgery between midnight and 7 AM when possible, as outcomes correlate with timing and availability of experienced personnel 1

Surgical Approach

  • For hemorrhagic gastritis, non-resectional surgery (such as oversewing bleeding points with vagotomy and pyloroplasty) is preferred over gastric resection 5, 6
  • Gastric resection should be avoided in hemorrhagic gastritis due to high postoperative mortality and rebleeding rates 5
  • In elderly patients or those with severe comorbidity, perform the minimum operation necessary to stop bleeding 1

Addressing Underlying Causes

Helicobacter pylori

  • Test all patients for H. pylori and provide eradication therapy if positive, as this dramatically reduces ulcer recurrence and rebleeding 1
  • Testing may have increased false-negative rates during acute bleeding; consider confirmatory testing after the acute episode if initial results are negative 1

NSAID-Associated Bleeding

  • Discontinue NSAIDs and aspirin (if used for primary prevention only) immediately 1
  • Aspirin for secondary cardiovascular prevention should be restarted as soon as hemostasis is achieved 1
  • If NSAIDs must be continued, use the least damaging agent (ibuprofen) with a proton pump inhibitor 1

Alcohol and Stress-Related Factors

  • Withdraw offending gastric irritants including alcohol 4, 7, 5
  • Provide intensive organ system support for critically ill patients with stress-related hemorrhagic gastritis 7

Common Pitfalls to Avoid

  • Do not delay endoscopy for PPI therapy; PPIs should be given concurrently, not sequentially 1
  • Do not use promotility agents routinely before endoscopy, as they do not improve diagnostic yield 1
  • Do not perform routine repeat endoscopy in all patients after initial successful therapy; reserve it for those with clinical rebleeding 1
  • Do not rush to surgery without attempting repeat endoscopy and considering interventional radiology first 1
  • Recognize that in hemorrhagic gastritis, bleeding ceases spontaneously with conservative treatment in the majority (75-89%) of cases 4, 5, 8

Post-Hemostasis Management

  • Low-risk patients can be fed within 24 hours and may be discharged promptly after endoscopy 1
  • Continue PPI therapy and arrange outpatient follow-up for H. pylori testing and eradication if not done during admission 1
  • For gastric ulcers, perform repeat endoscopy at 6 weeks to confirm healing and exclude malignancy 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antibiotic Prophylaxis for Cirrhotic Patients with Upper Gastrointestinal Bleeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Acute hemorrhagic gastritis.

Gastroenterology clinics of North America, 1993

Research

Acute hemorrhagic gastritis--diagnosis and treatment.

Acta chirurgica Scandinavica, 1976

Research

Hemorrhagic gastritis: current concepts.

Comprehensive therapy, 1978

Related Questions

What is the management plan for a gastrointestinal (GI) bleed due to mild gastritis?
What is the management strategy for hemorrhagic gastritis?
What is the optimal management for a patient with stress gastritis and diffuse gastric bleeding who is in shock after failed endoscopy?
Can gastritis cause upper gastrointestinal (GI) bleeding?
What are the causes of hemorrhagic gastritis besides nonsteroidal anti-inflammatory drugs (NSAIDs)?
How effective is laser therapy (fractional CO₂ or pulsed‑dye) for mature facial skin‑graft scars in an adult without infection, uncontrolled diabetes, or keloid tendency?
What is the normal reticulocyte count range for a newborn (0–28 days of age)?
What is the recommended approach to managing ventricular tachycardia, including assessment of hemodynamic stability, immediate synchronized cardioversion, antiarrhythmic drug selection (e.g., amiodarone, procainamide, lidocaine), electrolyte correction, beta‑blocker use, and indications for implantable cardioverter‑defibrillator placement?
Which of the listed medications (pantoprazole delayed‑release, sennosides, docusate sodium, ipratropium bromide inhaler [Atrovent HFA], lorazepam [Ativan], sitagliptin/metformin [Janumet], empagliflozin [Jardiance], lisinopril/hydrochlorothiazide, and atorvastatin) are known to cause dry mouth and/or a metallic taste?
Can pregnant women safely take Lexapro (escitalopram)?
How should a single episode of hematuria be evaluated and managed in an incontinent elderly patient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.